Exploring the Impact of Monocytes in Myeloproliferative Neoplasia (EMYNEM)

Sponsor
University Hospital, Brest
Study ID
NCT06462664
Status
Recruiting
Apply to this trial

Conditions

  • Myeloproliferative Neoplasm

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Impact of monocytes on Myeloproliferative Neoplasm hematopoietic stem cell growth and differentiation in vitro

Key Dates

First listed
Jun 17, 2024
Start date
Jun 1, 2024
Status verified
Jun 2024
Primary completion
Jan 31, 2028
Completion
Jan 31, 2028

Study Design

Enrollment
10 participants (estimated)

Primary Outcome Measure

Proliferation and differentiation of hematopoitic stem/progenitor cells [ Time Frame: 2 years ]

Central Contacts

Related Studies